Literature DB >> 23427430

[Characterization of Neisseria meningitidis strains isolated from carriers in Cuba during 20 years].

Isabel Martínez Motas1, Gustavo Sierra González, Niury Núñez Gutiérrez, Luis Izquierdo Pérez, Yanet Climent Ruíz, Mayelin Mirabal Sosa.   

Abstract

The epidemiological markers of Neisseria meningitidis strains isolated from carriers in Cuba for 20 years (1982-2002) were investigated. There were identified the serogroups, serotypes, subtypes and immunotypes of 331 strains corresponding to 2 different stages: epidemic (1982-1992) and postepidemic (1993-2002). A predominance of serogroup B (67.62%) and of non-groupable strains (32.28%) was observed in the epidemic stage, whereas the non-groupable strains (79.65%) and the serogroup B (17.26%) (p < 0.05) prevailed in the postepidemic stage. This study is the first and the only one up to now that investigates Neisseria meningitidis strains isolated from carriers before and after a national mass campaign of immunization with VA-MENGOC-BC (Cuban antimenigococcal vaccine against the serogroups B and C). The results obtained offered valuable data to the study, prevention and successful control of the meningococcal disease in Cuba, as well as to the development and evaluation of this vaccine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 23427430

Source DB:  PubMed          Journal:  Rev Cubana Med Trop        ISSN: 0375-0760


  5 in total

1.  Clonal distribution of disease-associated and healthy carrier isolates of Neisseria meningitidis between 1983 and 2005 in Cuba.

Authors:  Yanet Climent; Daniel Yero; Isabel Martinez; Alejandro Martín; Keith A Jolley; Franklin Sotolongo; Martin C J Maiden; Rachel Urwin; Rolando Pajón
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

Review 2.  The epidemiology of meningococcal disease in Latin America 1945-2010: an unpredictable and changing landscape.

Authors:  M A P Sáfadi; S González-Ayala; A Jäkel; H Wieffer; C Moreno; A Vyse
Journal:  Epidemiol Infect       Date:  2012-08-09       Impact factor: 2.451

3.  Cross-protection induced by VA-MENGOC-BC® vaccine.

Authors:  Rolando Felipe Ochoa-Azze
Journal:  Hum Vaccin Immunother       Date:  2018-02-26       Impact factor: 3.452

Review 4.  New versus old meningococcal group B vaccines: how the new ones may benefit infants & toddlers.

Authors:  D Panatto; D Amicizia; P L Lai; M L Cristina; A Domnich; R Gasparini
Journal:  Indian J Med Res       Date:  2013-12       Impact factor: 2.375

Review 5.  Carriage of Neisseria Meningitidis in Low and Middle Income Countries of the Americas and Asia: A Review of the Literature.

Authors:  Lidia Serra; Jessica Presa; Hannah Christensen; Caroline Trotter
Journal:  Infect Dis Ther       Date:  2020-04-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.